Pharmaceuticals News and Research

RSS

Small-molecule drug effective in protecting nonhuman primates from lethal Marburg virus

For the first time, scientists have demonstrated the effectiveness of a small-molecule drug in protecting nonhuman primates from the lethal Marburg virus. Their work, published online in the journal Nature, is the result of a continuing collaboration between Army scientists and industry partners that also shows promise for treating a broad range of other viral diseases.

5 Mar 2014

$Researchers develop silk-based surgical plates and screws to repair bone fractures$

Researchers develop silk-based surgical plates and screws to repair bone fractures

When a person suffers a broken bone, treatment calls for the surgeon to insert screws and plates to help bond the broken sections and enable the fracture to heal. These "fixation devices" are usually made of metal alloys.

5 Mar 2014

Drug firms trimming speaking fees to doctors

ProPublica examines a shift in the money that pharmaceutical companies gave physicans for promotional speeches.

5 Mar 2014

Viewpoints: Ryan's attack on Medicaid; time to fix Medicare's doc pay

House Budget Committee Chairman Paul D. Ryan, R-Wis., obviously is a great adherent of the adage, "If at first you don't succeed, try, try again." On Monday his committee released another attack on Medicaid, one of the linchpins of the Affordable Care Act and one that for some reason is especially detested by conservatives, like the majority members of Ryan's committee (Michael Hiltzik, 3/3).

5 Mar 2014

Mcl-1 protein enables NSCLC to survive radiation and drug treatments

Researchers at the Translational Genomics Research Institute have discovered a protein, Mcl-1, that helps enable one of the most common and deadly types of cancer to survive radiation and drug treatments.

5 Mar 2014

Bruker opens new preclinical imaging center of excellence for the Americas

Bruker (NASDAQ: BRKR) today announced the official opening of a new Preclinical Imaging Center of Excellence for the Americas in Billerica, Massachusetts. The facility offers advanced development, demonstration and support facilities for Bruker’s industry-leading portfolio of preclinical imaging instrumentation and multimodal platforms.

4 Mar 2014

Ambit to provide overview of quizartinib drug candidate at Barclays Global Healthcare Conference

Ambit Biosciences, a biopharmaceutical company focused on discovery and development of drugs targeting unmet needs in oncology, autoimmune and inflammatory disease, today announced the Company's participation at the Barclays Global Healthcare Conference to be held at the Loews Miami Hotel in Miami Beach, FL, March 10-13, 2014.

4 Mar 2014

Rigel Pharmaceuticals reports net loss of $16.9 million for fourth quarter 2013

Rigel Pharmaceuticals, Inc. today reported financial results for the fourth quarter and year ended December 31, 2013.

4 Mar 2014

First Edition: March 4, 2014

Today's headlines include highlights and themes from President Barack Obama's 2015 budget to be released today.

4 Mar 2014

NAFC honors Dr. Alan J. Wein with Rodney Appell Continence Care Champion award

The National Association For Continence presented Alan J. Wein, MD, FACS, PhD(hon) with its Rodney Appell Continence Care Champion award at the Society of Urodynamics, Female Pelvic Medicine, & Urogenital Reconstruction's 2014 Annual Meeting in Orlando, FL on February 28, 2014.

4 Mar 2014

Oramed to present detailed results from ORMD-0801 Phase 2a trial at 2014 GTC Diabetes Summit

Oramed Pharmaceuticals Inc., a clinical-stage pharmaceutical company focused on the development of oral drug delivery systems, announced today that it will be presenting detailed results from its recently completed Phase 2a FDA trial on ORMD-0801, its orally ingestible insulin capsule at the 2014 GTC Diabetes Summit taking place from April 23-25, 2014, in Boston, Massachusetts, USA.

4 Mar 2014

Sonoco launches Envoy Series for refrigerated and CRT shipping applications

Sonoco ThermoSafe, a unit of Sonoco (NYSE: SON) and a leading global provider of temperature assurance packaging, has added frozen (less than minus 20 degrees Celsius) configurations to its popular Envoy Series of pre-qualified shippers.

4 Mar 2014

AcelRx Pharmaceuticals announces financial results for fourth quarter and full year 2013

AcelRx Pharmaceuticals, Inc., a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of acute and breakthrough pain, today reported financial results for the three and twelve months ended December 31, 2013.

4 Mar 2014

AbbVie's PEARL-III study meets primary, secondary endpoints in patients with chronic GT1b HCV infection

The first detailed results from AbbVie's pivotal phase III study, PEARL-III, were presented today as part of the 21st Conference on Retroviruses and Opportunistic Infections (CROI) press conference and will also be presented as a late-breaker at the conference on March 4.

4 Mar 2014

ACADIA Pharmaceuticals proposes to sell common stock in underwritten public offering

ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) today announced that it intends to offer and sell, subject to market and other conditions, $150,000,000 of shares of its common stock in an underwritten public offering.

4 Mar 2014

Arrowhead receives approval to initiate Phase 2a clinical trial of ARC-520 for chronic HBV infection

Arrowhead Research Corporation (NASDAQ: ARWR), a biopharmaceutical company developing targeted RNAi therapeutics, today announced that it received regulatory approval to begin a Phase 2a clinical trial of ARC-520, its RNAi-based drug candidate for the treatment of chronic hepatitis B virus (HBV) infection.

4 Mar 2014

Intra-Cellular Therapies initiates Phase I/II clinical trial to evaluate pharmacokinetics in patients with dementia

Intra-Cellular Therapies, Inc., a biopharmaceutical company focused on the development of therapeutics for central nervous system (CNS) disorders, today announced the initiation of ITI-007-200, a Phase I/II clinical trial designed to evaluate the safety, tolerability and pharmacokinetics of low doses of its lead drug candidate, ITI-007, in healthy geriatric subjects and in patients with dementia, including Alzheimer's disease.

4 Mar 2014

OPKO Health consolidated revenues increase about 30% to $20.7 million in Q4 2013

OPKO Health, Inc., a multi-national biopharmaceutical and diagnostics company, today reported operating and financial results for its 2013 fourth quarter and full year ended December 31, 2013.

4 Mar 2014

Biostatistics provides clues to understanding autism: an interview with Dr Knut M. Wittkowski, The Rockefeller University

The incidence of autism spectrum disorders has increased sharply since it was first described 60 years ago. Today, ASD affects more than 1% of all children in the U.S. and about half of them develop a life-long disability.

3 Mar 2014

Akorn's consolidated revenue for fourth quarter 2013 increases 19% to $85 million

Akorn, Inc., a niche generic pharmaceutical company, today reported financial results for the fourth quarter and year-ended December 31, 2013.

3 Mar 2014

Pharmaceuticals News and Research

Small-molecule drug effective in protecting nonhuman primates from lethal Marburg virus

Researchers develop silk-based surgical plates and screws to repair bone fractures

Drug firms trimming speaking fees to doctors

Viewpoints: Ryan's attack on Medicaid; time to fix Medicare's doc pay

Mcl-1 protein enables NSCLC to survive radiation and drug treatments

Bruker opens new preclinical imaging center of excellence for the Americas

Ambit to provide overview of quizartinib drug candidate at Barclays Global Healthcare Conference

Rigel Pharmaceuticals reports net loss of $16.9 million for fourth quarter 2013

First Edition: March 4, 2014

NAFC honors Dr. Alan J. Wein with Rodney Appell Continence Care Champion award

Oramed to present detailed results from ORMD-0801 Phase 2a trial at 2014 GTC Diabetes Summit

Sonoco launches Envoy Series for refrigerated and CRT shipping applications

AcelRx Pharmaceuticals announces financial results for fourth quarter and full year 2013

AbbVie's PEARL-III study meets primary, secondary endpoints in patients with chronic GT1b HCV infection

ACADIA Pharmaceuticals proposes to sell common stock in underwritten public offering

Arrowhead receives approval to initiate Phase 2a clinical trial of ARC-520 for chronic HBV infection

Intra-Cellular Therapies initiates Phase I/II clinical trial to evaluate pharmacokinetics in patients with dementia

OPKO Health consolidated revenues increase about 30% to $20.7 million in Q4 2013

Biostatistics provides clues to understanding autism: an interview with Dr Knut M. Wittkowski, The Rockefeller University

Akorn's consolidated revenue for fourth quarter 2013 increases 19% to $85 million

Event guide: 3rd EHS for Biopharma Summit eBook

Latest eBooks

A practical guide to lipid nanoparticle formulation and resizing

Editorial Focus eBook - Spatial and single-cell omics (1st edition)

Industry Focus eBook - Analytical Chemistry (3rd edition)

Industry Focus eBook - Microbiome (1st edition)

Managing vibration in IVF laboratories

A New Approach to Preventing Bladder Cancer Recurrence

Bringing real-time analytics to downstream bioprocess monitoring